3Tao L, Gao E, Jia OX, et al. Adiponectin cardiopmteetion after myocar- dial ischemia-reperfusion involves the reduction of oxidative nitratives- tress[J].Circulation,2007,115 ( 11 ) : 1408-1416.
4Harrison A. B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea [ J ]. Ann Emerg Med,2009,39(2) :131-138.
5Pattetson JH, Rodgers JE. Expanding role of betahlokade in the man- agement of chronic heart failure [ J ]. Pharmacotherapy, 2008,23 ( 1 ) : 451- 459.
6Gtirgtin C, Ivdizli M, Yavuzgil O, et al. The effects of short-term statin treatment on left ventricular function and inflammatory markers in patients with chronic heart failurer[J]. Int J Cardiol,2008,123 (2) : 102-107.
7Zhu Jh, Quyyumi AA, Norman JE, et al. Effects of total pathogen bur- den on coronary artery disease risk and reactive protein levels[ J]. Am J Cardio1,2008,85 (6) : 140-146.
8Troughton RW, Richards AM. Outpatient monitoring and treatment of chronic heart failure guided by amino-tenminal pro-B type natriaretic peptide measurement[ J]. Am J Cardiol,2008,101 (3A) :72-75.
9Tang WH, Fancls GS, Morrow DA, et al. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical utiliza- tion of cardiac biomarker testing inheart failure [ J ]. Clin Biochem, 2008,41 (4-5) :210-221.
